Amneal 制药 AMRX
$20.14 +$0.69 (+3.55%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $20.14 0.00%
开盘$19.45
昨收$19.45
当日区间$19.30 – $20.43
成交量4.73M
市值$6.43B
市盈率（TTM）50.4
股息率–
AMRX 相关新闻
匹配 Amneal Pharmaceuticals 或代码 AMRX 的头条新闻，按最新排序。
- Leerink Partners Initiates Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Announces Target Price $23
- J.P. Morgan Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating
- Barclays Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $20
- Barclays Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Raises Target Price to $20 正面
- Leerink Partners Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $23
- UBS Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Raises Target Price to $25 正面
- J.P. Morgan Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Raises Target Price to $22 正面
- Goldman Sachs Initiates Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Announces Target Price $21
- Goldman Sachs Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Raises Target Price to $21 正面
- Goldman Sachs Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $19
- Goldman Sachs Initiates Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Announces Target Price $19
- UBS Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Announces Target Price $23
- Piper Sandler Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $17
- UBS Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating
- Barclays Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $16
暂无评论——快来第一个聊聊 AMRX。